This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Assistance Publique-Hopitaux De Paris, Centre National De La Recherche Scientifique, Institut Pasteur. Active years: 2014-2018.
Company Filing History:
3 out of 331 
3 out of 5,383 
3 out of 897 
Years Active: 2014-2018
Title: The Innovations of Patrick Trieu-Cuot
Introduction
Patrick Trieu-Cuot is a notable inventor based in Fontenay aux Roses, France. He has made significant contributions to the field of biotechnology, particularly in the detection of highly-virulent bacterial clones. With a total of 3 patents to his name, Trieu-Cuot's work has implications for public health and disease management.
Latest Patents
Trieu-Cuot's latest patents focus on polynucleotides that enable the rapid, simple, and specific detection of Group B highly-virulent ST-17 clones. These inventions also encompass the polypeptides encoded by the polynucleotides, as well as antibodies directed against these polypeptides. Furthermore, his patents include kits and methods for the specific detection of these dangerous bacterial clones, utilizing the innovative polynucleotides, polypeptides, or antibodies.
Career Highlights
Throughout his career, Patrick Trieu-Cuot has worked with prestigious institutions such as Institut Pasteur and the Centre National de la Recherche Scientifique. His research has been pivotal in advancing the understanding of bacterial infections and developing effective detection methods.
Collaborations
Trieu-Cuot has collaborated with esteemed colleagues, including Claire Poyart and Marie-Cécile Lamy. These partnerships have contributed to the success of his research and innovations.
Conclusion
Patrick Trieu-Cuot's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to impact public health positively.